Novel models of metastasis must be developed to initiate new therapeutic approaches, since metastases from colorectal carcinoma (CRC) still kill 45% of patients. In the parent R01 grant CRC cells injected intrasplenically into athymic nude mice is a useful model because growth in liver is significantly associated with prognosis in patients. However, this in vivo model is expensive and cumbersome. We have now developed an in vitro organotypic culture system that uses a NASA-designed rotating wall vessel (RWV) bioreactor to promote cell and tissue colocalization with low shear stress. The RWV approximates solid body rotation by rotating cells and tissues in aqueous medium around the horizontal axis. Normal mouse liver fragments and cells are viable in the RWV for at least 8-10 days. Using the RWV with ischemic mouse liver reoxygenated in vitro and co-cultured with CRC, we have recreated the survival kinetics of CRC in the first 24 hr. In this supplemental application we propose to extend this in vitro model from 24 hr to 7 days and determine whether it can be used to assess the importance of host cytokine and growth factor interactions. Our overall hypothesis is that organotypic culture in an RWV recreates the host-tumor microenvironment during the first week of metastasis with sufficient fidelity to predict the ability of human CRC to colonize liver in vivo. Our secondary postulate is that carcinoembryonic antigen (CEA), IL-10, IL-6 and/or pleiotrophin are essential growth factors for human CRC metastasis.
Our specific aims are to: 1.) Establish the kinetics of cell number, viability, and S phase fraction in vivo after CX-1 or Clone A cells are injected intrasplenically; 2.) Determine the optimal conditions for murine liver fragment:CRC cell co-culture to best approximate the proliferation of CRC cells in vivo in the liver after intrasplenic injection; 3.) Determine whether CEA and the cytokines that it induces, IL-6 and IL-10, effect CRC cell proliferation in the RWV co-cultures after the first 24 hr; and 4.) Determine whether pleiotrophin (PTN) is an essential growth factor for CRC metastasis in vivo and the RWV in vitro. Our overall purpose is to extend the original R01 into a more robust model of the first 7 days of liver colonization and to develop an organotypic model that uses fewer mice but facilitates preclinical testing of new therapies for metastasis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA042857-15S1
Application #
6585452
Study Section
Special Emphasis Panel (ZCA1-SRRB-K (O1))
Program Officer
Jhappan, Chamelli
Project Start
1986-05-01
Project End
2005-04-30
Budget Start
2002-08-15
Budget End
2003-04-30
Support Year
15
Fiscal Year
2002
Total Cost
$77,600
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Chen, Jian; Zaidi, Sobia; Rao, Shuyun et al. (2018) Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-? Pathway. Gastroenterology 154:195-210
Chen, Jian; Shukla, Vivek; Farci, Patrizia et al. (2017) Loss of the transforming growth factor-? effector ?2-Spectrin promotes genomic instability. Hepatology 65:678-693
Shin, Joshua; Mishra, Viveka; Glasgow, Eric et al. (2017) PRAJA is overexpressed in glioblastoma and contributes to neural precursor development. Genes Cancer 8:640-649
Chen, Jian; Raju, Gottumukkala S; Jogunoori, Wilma et al. (2016) Mutational Profiles Reveal an Aberrant TGF-?-CEA Regulated Pathway in Colon Adenomas. PLoS One 11:e0153933
Chen, Jian; Shukla, Vivek; Farci, Patrizia et al. (2016) Loss of the TGF-? Effector ?2SP Promotes Genomic Instability. Hepatology :
Chen, Jian; Herlong, Franklin H; Stroehlein, John R et al. (2016) Mutations of Chromatin Structure Regulating Genes in Human Malignancies. Curr Protein Pept Sci 17:411-37
Chen, Jian; Yao, Zhi-Xing; Chen, Jiun-Sheng et al. (2016) TGF-?/?2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. J Clin Invest 126:527-42
Muñoz, Nina M; Katz, Lior H; Shina, Ji-Hyun et al. (2014) Generation of a mouse model of T-cell lymphoma based on chronic LPS challenge and TGF-? signaling disruption. Genes Cancer 5:348-352
Katz, Lior H; Li, Ying; Chen, Jiun-Sheng et al. (2013) Targeting TGF-? signaling in cancer. Expert Opin Ther Targets 17:743-60
Blechacz, Boris; Mishra, Lopa (2013) Hepatocellular carcinoma biology. Recent Results Cancer Res 190:1-20

Showing the most recent 10 out of 49 publications